Dallabetta Gina, Neilson Graham
Institute for HIV/AIDS, Family Health International, 2101 Wilson Boulevard, Suite 700, Arlington, VA 22201, USA.
Curr HIV/AIDS Rep. 2004 Dec;1(4):166-71. doi: 10.1007/s11904-004-0026-7.
There is overwhelming and compelling evidence that control efforts for STI have a major role to play in the prevention of HIV transmission. Community-based randomized controlled trials are set as the highest standard of evidence for showing the efficacy of STI interventions to prevent HIV transmission. The negative results of recent randomized controlled trials have cast doubt on the positive findings of the Mwanza study. Deeper analysis of the result of these trials has improved understanding of the role of STI interventions and augmented the wealth of evidence provided by numerous epidemiological and biomedical studies. Apart from the biological impact of effective treatment of curable STIs on HIV transmission, clinical services also support the reduction of HIV-risk behaviors. STI interventions should limit the scale of the impending epidemics in Asia and Eastern Europe, depending on the priority that they are given by governments and major donor agencies.
有压倒性且令人信服的证据表明,性传播感染防控工作在预防艾滋病毒传播方面可发挥重要作用。基于社区的随机对照试验被视为证明性传播感染干预措施预防艾滋病毒传播有效性的最高证据标准。近期随机对照试验的阴性结果对姆万扎研究的阳性发现提出了质疑。对这些试验结果进行更深入分析,增进了对性传播感染干预措施作用的理解,并丰富了众多流行病学和生物医学研究提供的证据。除了有效治疗可治愈性传播感染对艾滋病毒传播产生的生物学影响外,临床服务也有助于减少艾滋病毒风险行为。性传播感染干预措施应能限制亚洲和东欧即将出现的疫情规模,这取决于政府和主要捐助机构对它们的重视程度。